AIM logo

AIM ImmunoTech (AIM) Return On Equity

Annual ROE

-118.94%
-78.15%-191.59%

December 31, 2023


Summary


Performance

AIM ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAIMprofitabilitymetrics:

Quarterly ROE

-256.33%
-66.58%-35.09%

September 30, 2024


Summary


Performance

AIM Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAIMprofitabilitymetrics:

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

AIM ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-191.6%-141.5%
3 y3 years-208.6%-417.0%
5 y5 years+16.0%-417.0%

AIM ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-267.4%at low-748.8%at low
5 y5-year-267.4%at low-895.5%at low
alltimeall time-481.9%+41.3%-1982.3%+2.0%

AIM ImmunoTech ROE History

DateAnnualQuarterly
Sep 2024
-
-256.33%(+35.1%)
Jun 2024
-
-189.75%(+25.4%)
Mar 2024
-
-151.37%(+42.6%)
Dec 2023
-118.94%(+191.6%)
-106.14%(+72.6%)
Sep 2023
-
-61.50%(+24.0%)
Jun 2023
-
-49.58%(+12.2%)
Mar 2023
-
-44.19%(+9.1%)
Dec 2022
-40.79%(+26.0%)
-40.49%(+2.2%)
Sep 2022
-
-39.63%(+23.8%)
Jun 2022
-
-32.01%(+2.0%)
Mar 2022
-
-31.37%(+3.9%)
Dec 2021
-32.37%(-16.0%)
-30.20%(+12.6%)
Sep 2021
-
-26.82%(-1.7%)
Jun 2021
-
-27.29%(+6.0%)
Mar 2021
-
-25.75%(-22.2%)
Dec 2020
-38.54%(-61.9%)
-33.08%(-2.3%)
Sep 2020
-
-33.86%(-29.8%)
Jun 2020
-
-48.25%(-28.6%)
Mar 2020
-
-67.62%(-38.3%)
Dec 2019
-101.03%(-28.7%)
-109.60%(-21.0%)
Sep 2019
-
-138.72%(-14.3%)
Jun 2019
-
-161.93%(+7.7%)
Mar 2019
-
-150.39%(+21.2%)
Dec 2018
-141.63%(+107.5%)
-124.04%(+8.2%)
Sep 2018
-
-114.65%(+32.5%)
Jun 2018
-
-86.55%(+10.9%)
Mar 2018
-
-78.04%(+8.7%)
Dec 2017
-68.25%(+63.2%)
-71.79%(+26.3%)
Sep 2017
-
-56.83%(-8.4%)
Jun 2017
-
-62.07%(+23.2%)
Mar 2017
-
-50.38%(+18.7%)
Dec 2016
-41.83%(-37.7%)
-42.43%(-13.9%)
Sep 2016
-
-49.27%(+0.6%)
Jun 2016
-
-49.00%(-18.7%)
Mar 2016
-
-60.29%(-3.2%)
Dec 2015
-67.13%(+4.4%)
-62.28%(-3.5%)
Sep 2015
-
-64.51%(+2.4%)
Jun 2015
-
-63.02%(+3.2%)
Mar 2015
-
-61.06%(-0.6%)
Dec 2014
-64.27%(+46.6%)
-61.43%(+13.2%)
Sep 2014
-
-54.26%(+0.7%)
Jun 2014
-
-53.86%(+12.0%)
Mar 2014
-
-48.11%(+8.9%)
Dec 2013
-43.85%(+4.4%)
-44.17%(-8.7%)
Sep 2013
-
-48.40%(-6.6%)
Jun 2013
-
-51.83%(+6.9%)
Mar 2013
-
-48.49%(+5.6%)
Dec 2012
-41.99%(+95.4%)
-45.92%(+13.1%)
Sep 2012
-
-40.61%(+39.6%)
Jun 2012
-
-29.09%(+13.7%)
Mar 2012
-
-25.59%(+21.6%)
Dec 2011
-21.49%(-14.4%)
-21.05%(+15.0%)
Sep 2011
-
-18.30%(-5.8%)
Jun 2011
-
-19.42%(+16.8%)
Mar 2011
-
-16.62%(-31.2%)
Dec 2010
-25.11%
-24.14%(+67.6%)
Sep 2010
-
-14.40%(+17.0%)
Jun 2010
-
-12.31%(-37.8%)
DateAnnualQuarterly
Mar 2010
-
-19.80%(+6.1%)
Dec 2009
-20.44%(-72.8%)
-18.66%(-55.3%)
Sep 2009
-
-41.74%(-39.5%)
Jun 2009
-
-68.98%(-22.7%)
Mar 2009
-
-89.28%(+15.5%)
Dec 2008
-75.20%(-5.3%)
-77.33%(+9.8%)
Sep 2008
-
-70.40%(-2.3%)
Jun 2008
-
-72.03%(+3.6%)
Mar 2008
-
-69.51%(-5.6%)
Dec 2007
-79.37%(-11.3%)
-73.65%(-5.8%)
Sep 2007
-
-78.17%(+11.5%)
Jun 2007
-
-70.12%(-5.9%)
Mar 2007
-
-74.50%(-11.0%)
Dec 2006
-89.44%(+44.4%)
-83.69%(-4.0%)
Sep 2006
-
-87.18%(-0.1%)
Jun 2006
-
-87.24%(+3.8%)
Mar 2006
-
-84.04%(+16.0%)
Dec 2005
-61.94%(-43.5%)
-72.42%(+168.7%)
Sep 2005
-
-26.95%(-47.2%)
Jun 2005
-
-51.01%(-26.8%)
Mar 2005
-
-69.66%(-36.6%)
Dec 2004
-109.63%(-45.8%)
-109.87%(-43.3%)
Sep 2004
-
-193.68%(-17.2%)
Jun 2004
-
-233.95%(-10.5%)
Mar 2004
-
-261.50%(+28.3%)
Dec 2003
-202.45%(+109.1%)
-203.83%(+4.1%)
Sep 2003
-
-195.75%(+42.5%)
Jun 2003
-
-137.33%(+17.0%)
Mar 2003
-
-117.42%(+21.2%)
Dec 2002
-96.80%(+19.0%)
-96.87%(-3.2%)
Sep 2002
-
-100.08%(+2.4%)
Jun 2002
-
-97.73%(+7.6%)
Mar 2002
-
-90.83%(-6.5%)
Dec 2001
-81.33%(+15.4%)
-97.14%(+0.3%)
Sep 2001
-
-96.88%(+15.7%)
Jun 2001
-
-83.73%(+15.5%)
Mar 2001
-
-72.51%(+11.6%)
Dec 2000
-70.47%(-20.1%)
-64.96%(-25.9%)
Sep 2000
-
-87.71%(-2.4%)
Jun 2000
-
-89.86%(-7.6%)
Mar 2000
-
-97.23%(-7.0%)
Dec 1999
-88.16%(+56.4%)
-104.54%(+32.4%)
Sep 1999
-
-78.95%(+0.6%)
Jun 1999
-
-78.48%(+10.1%)
Mar 1999
-
-71.31%(+16.3%)
Dec 1998
-56.37%(-23.3%)
-61.34%(-5.1%)
Sep 1998
-
-64.66%(-24.4%)
Jun 1998
-
-85.55%(-1.5%)
Mar 1998
-
-86.89%(-23.1%)
Dec 1997
-73.49%(-17.7%)
-112.96%(-14.4%)
Sep 1997
-
-131.91%(+1.3%)
Jun 1997
-
-130.25%(+0.4%)
Mar 1997
-
-129.71%(+33.1%)
Dec 1996
-89.32%(+118.3%)
-97.46%(+19.8%)
Sep 1996
-
-81.36%(+9.5%)
Jun 1996
-
-74.29%(+50.4%)
Mar 1996
-
-49.38%(+20.7%)
Dec 1995
-40.91%
-40.91%

FAQ

  • What is AIM ImmunoTech annual return on equity?
  • What is the all time high annual ROE for AIM ImmunoTech?
  • What is AIM ImmunoTech annual ROE year-on-year change?
  • What is AIM ImmunoTech quarterly return on equity?
  • What is the all time high quarterly ROE for AIM ImmunoTech?
  • What is AIM ImmunoTech quarterly ROE year-on-year change?

What is AIM ImmunoTech annual return on equity?

The current annual ROE of AIM is -118.94%

What is the all time high annual ROE for AIM ImmunoTech?

AIM ImmunoTech all-time high annual return on equity is -20.44%

What is AIM ImmunoTech annual ROE year-on-year change?

Over the past year, AIM annual return on equity has changed by -78.15% (-191.59%)

What is AIM ImmunoTech quarterly return on equity?

The current quarterly ROE of AIM is -256.33%

What is the all time high quarterly ROE for AIM ImmunoTech?

AIM ImmunoTech all-time high quarterly return on equity is -12.31%

What is AIM ImmunoTech quarterly ROE year-on-year change?

Over the past year, AIM quarterly return on equity has changed by -150.19% (-141.50%)